-+ 0.00%
-+ 0.00%
-+ 0.00%

Personalis wins UKCA mark for NeXT Personal Dx MRD test in Great Britain

PUBT·07/14/2026 10:01:09
Listen to the news
Personalis wins UKCA mark for NeXT Personal Dx MRD test in Great Britain
  • Personalis won UKCA marking for its NeXT Personal Dx minimal residual disease test, clearing clinical use across Great Britain.
  • The regulatory clearance broadens access to its ctDNA-based test, supporting standardized MRD monitoring in multinational biopharma trials.
  • Link Medical Solutions will partner on commercialization in Great Britain.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Personalis Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260714263128) on July 14, 2026, and is solely responsible for the information contained therein.